FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maria Theodoulou-Haber

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Angelo E Volandes; Elizabeth S Walker-Corkery; Eileen M O'Reilly; Susan Slovin; Maria Theodoulou-Haber; Richard D Carvajal; Yuchiao Chang; Maura Dickler; Andrew S Epstein; John F Gerecitano; Mary-Louise Keohan; Tomer T Levin; Michael Morris; Anastazia Naka-Blackstone; Ariela Noy
Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention study.
Ayca Gucalp; Clifford Hudis; Joan Massague; Larry Norton; Sujata Patil; Christine Pellegrino; Jean Santamauro; Joseph A Sparano; Maria Theodoulou-Haber; Alyson Abbruzzi; Jackie Bromberg; James Caravelli; Chau Dang; Tiffany A Traina
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.
Devika Gajria; Stephanie Geneus; Clifford A Hudis; Larry Norton; Sujata Patil; Lee K Tan; Maria Theodoulou-Haber; Kimberly Feigin; Tiffany A Traina
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maria Theodoulou-Haber (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Angelo E Volandes; Elizabeth S Walker-Corkery; Eileen M O'Reilly; Susan Slovin; Maria Theodoulou-Haber; Richard D Carvajal; Yuchiao Chang; Maura Dickler; Andrew S Epstein; John F Gerecitano; Mary-Louise Keohan; Tomer T Levin; Michael Morris; Anastazia Naka-Blackstone; Ariela Noy
Augmenting advance care planning in poor prognosis cancer with a video decision aid: a preintervention-postintervention study.
Cancer 2012;118(17):4331-8.
2011: Ayca Gucalp; Clifford Hudis; Joan Massague; Larry Norton; Sujata Patil; Christine Pellegrino; Jean Santamauro; Joseph A Sparano; Maria Theodoulou-Haber; Alyson Abbruzzi; Jackie Bromberg; James Caravelli; Chau Dang; Tiffany A Traina
Phase II trial of saracatinib (AZD0530), an oral SRC-inhibitor for the treatment of patients with hormone receptor-negative metastatic breast cancer.
Clinical breast cancer 2011;11(5):306-11.
2011: Devika Gajria; Stephanie Geneus; Clifford A Hudis; Larry Norton; Sujata Patil; Lee K Tan; Maria Theodoulou-Haber; Kimberly Feigin; Tiffany A Traina
Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer.
Cancer 2011;117(18):4125-31.
2010: Conleth G Murphy; Joseph B Walsh; Clifford Hudis; Diana Lake; Maria Theodoulou-Haber
Cystoid macular edema secondary to nab-paclitaxel therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):e684-7.
2010: Tiffany A Traina; Hope S Rugo; James Caravelli; Sujata M Patil; Benjamin Yeh; Michele E Melisko; John W Park; Stephanie Geneus; Matthew Paulson; Jill Grothusen; Andrew D Seidman; Monica Fornier; Diana E Lake; Chau Dang; Mark Robson; Maria Theodoulou-Haber; Carlos D Flombaum; Larry Norton; Clifford Hudis; Maura Dickler
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(4):628-33.
2010: Tiffany A Traina; Ute Dugan; Brian Higgins; Kenneth Kolinsky; Maria Theodoulou-Haber; Clifford A Hudis; Larry Norton
Optimizing chemotherapy dose and schedule by Norton-Simon mathematical modeling.
Breast disease 2010;31(1):7-18.
2009: Yunfeng Cui; Yongqiang Tan; Binsheng Zhao; Laura Liberman; Rakesh Parbhu; Jennifer Kaplan; Maria Theodoulou-Haber; Clifford Hudis; Lawrence H Schwartz
Malignant lesion segmentation in contrast-enhanced breast MR images based on the marker-controlled watershed.
Medical physics 2009;36(10):4359-69.
2009: Hyman Muss; Donald A Berry; Constance Cirrincione; Maria Theodoulou-Haber; Ann M Mauer; Alice B Kornblith; Ann H Partridge; Lynn Dressler; Harvey J Cohen; Heather P Becker; Patricia A Kartcheske; Judith D Wheeler; Edith A Perez; Antonio C Wolff; Julie R Gralow; Harold J Burstein; Ahmad A Mahmood; Gustav Magrinat; Gutav Magrinat; Barbara A Parker; Ronald D Hart; Debjani Grenier; Larry Norton; Clifford Hudis; Eric P Winer
Adjuvant chemotherapy in older women with early-stage breast cancer.
The New England journal of medicine 2009;360(20):2055-65.
2009: Maria Theodoulou-Haber; Gerald Batist; Susana Campos; Eric P Winer; Lauri Welles; Clifford Hudis
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer.
Clinical breast cancer 2009;9(2):101-7.
2008: Tiffany A Traina; Maria Theodoulou-Haber; Kimberly Feigin; Sujata M Patil; K Lee Tan; Charles Edwards; Ute Dugan; Larry Norton; Clifford Hudis
Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(11):1797-802.
2007: Constantinos T Sofocleous; Rodrigo G Nascimento; Mithat Gonen; Maria Theodoulou-Haber; Anne M Covey; Lynn A Brody; Stephen B Solomon; Raymond H Thornton; Yuman Fong; George I Getrajdman; Karen T Brown
Radiofrequency ablation in the management of liver metastases from breast cancer.
AJR. American journal of roentgenology 2007;189(4):883-9.
2006: Antonio Llombart-Cussac; Maria Theodoulou-Haber; Kendrith M Rowland; Romnee S Clark; Takashi Nakamura; Eva Carrasco; Giorgio Cruciani
Pemetrexed in patients with locally advanced or metastatic breast cancer who had received previous anthracycline and taxane treatment: phase II study.
Clinical breast cancer 2006;7(5):380-5.
2006: Arti Hurria; Shari Goldfarb; Carol Rosen; Jimmie C Holland; Enid Zuckerman; Mark S Lachs; Matthew Witmer; Wilfred G van Gorp; Monica Fornier; Gabriella D'Andrea-Carlino; Mark M Moasser; Chau Dang; Catherine Van Poznak; Mark Robson; Violante E Currie; Maria Theodoulou-Haber; Larry Norton; Clifford Hudis
Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
Breast cancer research and treatment 2006;98(3):343-8.
2006: Arti Hurria; Anju Hurria; Enid Zuckerman; Katherine S Panageas; Monica Fornier; Gabriella D'Andrea-Carlino; Chau Dang; Mark M Moasser; Mark Robson; Andrew D Seidman; Violante E Currie; Catherine Van Poznak; Maria Theodoulou-Haber; Mark S Lachs; Clifford Hudis
A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy.
Journal of the American Geriatrics Society 2006;54(7):1119-24.
2005: Shanu Modi; Violante E Currie; Andrew D Seidman; Ariadne M Bach; Katherine S Panageas; Maria Theodoulou-Haber; Mark M Moasser; Gabriella D'Andrea-Carlino; Diana E Lake; Jennifer Choi; Larry Norton; Clifford Hudis
A phase II trial of gemcitabine in patients with metastatic breast cancer previously treated with an anthracycline and taxane.
Clinical breast cancer 2005;6(1):55-60.
2004: Chau Dang; Gabriella D'Andrea-Carlino; Mary Ellen Moynahan; Maura Dickler; Andrew D Seidman; Monica Fornier; Mark Robson; Maria Theodoulou-Haber; Diana E Lake; Violante E Currie; Arti Hurria; Katherine S Panageas; Larry Norton; Clifford Hudis
Phase II study of feasibility of dose-dense FEC followed by alternating weekly taxanes in high-risk, four or more node-positive breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5754-61.
2004: Chau Dang; Andrew J Dannenberg; Kotha Subbaramaiah; Maura Dickler; Mark M Moasser; Andrew D Seidman; Gabriella D'Andrea-Carlino; Maria Theodoulou-Haber; Katherine S Panageas; Larry Norton; Clifford Hudis
Phase II study of celecoxib and trastuzumab in metastatic breast cancer patients who have progressed after prior trastuzumab-based treatments.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(12 Pt 1):4062-7.
2004: Maria Theodoulou-Haber; Clifford Hudis
Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?
Cancer 2004;100(10):2052-63.
2003: Maria Theodoulou-Haber; Andrew D Seidman
Cardiac effects of adjuvant therapy for early breast cancer.
Seminars in oncology 2003;30(6):730-9.
2001: Monica Fornier; Andrew D Seidman; Maria Theodoulou-Haber; Mary Ellen Moynahan; Violante E Currie; Mark M Moasser; Nancy T Sklarin; Teresa A Gilewski; Gabriella D'Andrea-Carlino; R Salvaggio; Katherine S Panageas; Larry Norton; Clifford Hudis
Doxorubicin followed by sequential paclitaxel and cyclophosphamide versus concurrent paclitaxel and cyclophosphamide: 5-year results of a phase II randomized trial of adjuvant dose-dense chemotherapy for women with node-positive breast carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(12):3934-41.
2001: Andrew D Seidman; Monica Fornier; Francisco J Esteva; Lee Tan; S Kaptain; Ariadne M Bach; Katherine S Panageas; Crispinita D Arroyo; V Valero; Violante E Currie; Teresa A Gilewski; Maria Theodoulou-Haber; Mary Ellen Moynahan; Mark M Moasser; Nancy T Sklarin; Maura Dickler; Gabriella D'Andrea-Carlino; M Cristofanilli; E Rivera; Gabriel N Hortobagyi; Larry Norton; Clifford Hudis
Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2587-95.
1999: Clifford Hudis; Monica Fornier; L Riccio; David Lebwohl; John Crown; Teresa A Gilewski; A Surbone; Violante E Currie; Andrew D Seidman; B Reichman; Mary Ellen Moynahan; G Raptis; Nancy T Sklarin; Maria Theodoulou-Haber; L Weiselberg; R Salvaggio; Katherine S Panageas; Tzy-Jyun Yao; Larry Norton
5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(4):1118.
1999: Gabriella D'Andrea-Carlino; DW Fennelly; Larry Norton; José Baselga; Teresa A Gilewski; Clifford Hudis; Mary Ellen Moynahan; G Raptis; Nancy T Sklarin; A Surbone; Maria Theodoulou-Haber; M A Templeton; Tzy-Jyun Yao; Andrew D Seidman
Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):275-9.
1999: DK Payne; Rosalind Hoffman; Maria Theodoulou-Haber; M Dosik; Mary Jane Massie
Screening for anxiety and depression in women with breast cancer. Psychiatry and medical oncology gear up for managed care.
Psychosomatics 1999;40(1):64-9.
1998: Andrew D Seidman; Clifford Hudis; J Albanell; J Albanel; William Tong; I Tepler; Violante E Currie; Mary Ellen Moynahan; Maria Theodoulou-Haber; Marc J Gollub; José Baselga; Larry Norton
Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3353-61.
1997: Andrew D Seidman; Clifford Hudis; John McCaffrey; William Tong; Violante E Currie; Mary Ellen Moynahan; Maria Theodoulou-Haber; I Tepler; Marc J Gollub; Larry Norton
Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-72-S17-76.
1996: Clifford Hudis; Andrew D Seidman; G Raptis; DW Fennelly; Teresa A Gilewski; José Baselga; Maria Theodoulou-Haber; Nancy T Sklarin; Mary Ellen Moynahan; A Surbone; Violante E Currie; David Lebwohl; M Uhlenhopp; John Crown; Larry Norton
Sequential adjuvant therapy: the Memorial Sloan-Kettering Cancer Center experience.
Seminars in oncology 1996;23(1 Suppl 1):58-64.